| SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition A Nelde, T Bilich, JS Heitmann, Y Maringer, HR Salih, M Roerden, ... Nature immunology 22 (1), 74-85, 2021 | 587 | 2021 |
| Analysis of major histocompatibility complex (MHC) immunopeptidomes using mass spectrometry E Caron, DJ Kowalewski, CC Koh, T Sturm, H Schuster, R Aebersold Molecular & Cellular Proteomics 14 (12), 3105-3117, 2015 | 236 | 2015 |
| HLA ligandome analysis identifies the underlying specificities of spontaneous antileukemia immune responses in chronic lymphocytic leukemia (CLL) DJ Kowalewski, H Schuster, L Backert, C Berlin, S Kahn, L Kanz, ... Proceedings of the National Academy of Sciences 112 (2), E166-E175, 2015 | 189 | 2015 |
| Improved Ribo-seq enables identification of cryptic translation events F Erhard, A Halenius, C Zimmermann, A L'Hernault, DJ Kowalewski, ... Nature methods 15 (5), 363-366, 2018 | 171 | 2018 |
| The immunopeptidomic landscape of ovarian carcinomas H Schuster, JK Peper, HC Bösmüller, K Röhle, L Backert, T Bilich, B Ney, ... Proceedings of the National Academy of Sciences 114 (46), E9942-E9951, 2017 | 170 | 2017 |
| Mapping the HLA ligandome landscape of acute myeloid leukemia: a targeted approach toward peptide-based immunotherapy C Berlin, DJ Kowalewski, H Schuster, N Mirza, S Walz, M Handel, ... Leukemia 29 (3), 647-659, 2015 | 156 | 2015 |
| HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy A Marcu, L Bichmann, L Kuchenbecker, DJ Kowalewski, ... Journal for immunotherapy of cancer 9 (4), 2021 | 151 | 2021 |
| The SysteMHC atlas project W Shao, PGA Pedrioli, W Wolski, C Scurtescu, E Schmid, JA Vizcaíno, ... Nucleic acids research 46 (D1), D1237-D1247, 2018 | 139 | 2018 |
| An open-source computational and data resource to analyze digital maps of immunopeptidomes E Caron, L Espona, DJ Kowalewski, H Schuster, N Ternette, A Alpízar, ... Elife 4, e07661, 2015 | 128 | 2015 |
| The antigenic landscape of multiple myeloma: mass spectrometry (re) defines targets for T-cell–based immunotherapy S Walz, JS Stickel, DJ Kowalewski, H Schuster, K Weisel, L Backert, ... Blood, The Journal of the American Society of Hematology 126 (10), 1203-1213, 2015 | 115 | 2015 |
| Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma MW Löffler, C Mohr, L Bichmann, LK Freudenmann, M Walzer, ... Genome medicine 11, 1-16, 2019 | 110 | 2019 |
| Biochemical large-scale identification of MHC class I ligands DJ Kowalewski, S Stevanović Antigen Processing: Methods and Protocols, 145-157, 2013 | 101 | 2013 |
| Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient MW Löffler, PA Chandran, K Laske, C Schroeder, I Bonzheim, M Walzer, ... Journal of hepatology 65 (4), 849-855, 2016 | 86 | 2016 |
| Identification of non-mutated neoantigens presented by TAP-deficient tumors KA Marijt, L Blijleven, EME Verdegaal, MG Kester, DJ Kowalewski, ... Journal of Experimental Medicine 215 (9), 2325-2337, 2018 | 70 | 2018 |
| The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy T Bilich, A Nelde, L Bichmann, M Roerden, HR Salih, DJ Kowalewski, ... Blood, The Journal of the American Society of Hematology 133 (6), 550-565, 2019 | 68 | 2019 |
| A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer HG Rammensee, KH Wiesmüller, PA Chandran, H Zelba, E Rusch, ... Journal for immunotherapy of cancer 7, 1-18, 2019 | 64 | 2019 |
| Mapping the HLA ligandome of colorectal cancer reveals an imprint of malignant cell transformation MW Löffler, DJ Kowalewski, L Backert, J Bernhardt, P Adam, H Schuster, ... Cancer research 78 (16), 4627-4641, 2018 | 59 | 2018 |
| Purification and identification of naturally presented MHC class I and II ligands A Nelde, DJ Kowalewski, S Stevanović Antigen Processing: Methods and Protocols, 123-136, 2019 | 58 | 2019 |
| MHC-I ligand discovery using targeted database searches of mass spectrometry data: implications for T-cell immunotherapies JP Murphy, P Konda, DJ Kowalewski, H Schuster, D Clements, Y Kim, ... Journal of proteome research 16 (4), 1806-1816, 2017 | 51 | 2017 |
| HLA ligandome analysis of primary chronic lymphocytic leukemia (CLL) cells under lenalidomide treatment confirms the suitability of lenalidomide for combination with T-cell … A Nelde, DJ Kowalewski, L Backert, H Schuster, JO Werner, R Klein, ... Oncoimmunology 7 (4), e1316438, 2018 | 48 | 2018 |
Markus W. LöfflerPhysician-Scientist (MD), University of Tübingen (Germany), Depts. of Immunology/ General Surgery.Verified email at med.uni-tuebingen.de
